Microdeletions of 3q29 confer high risk for schizophrenia.
about
Human genetics and genomics a decade after the release of the draft sequence of the human genomeCNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1The PHR proteins: intracellular signaling hubs in neuronal development and axon degenerationGenetics and genomics of psychiatric diseaseAbnormal kalirin signaling in neuropsychiatric disorders.Differential expression of PDZ domain-containing proteins in human diseases - challenging topics and novel issuesThe impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophreniaCopy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplicationsMosaic copy number variation in schizophreniaMicroarray Analysis of Copy Number Variants on the Human Y Chromosome Reveals Novel and Frequent Duplications Overrepresented in Specific HaplogroupsMultiplex ligation-dependant probe amplification study of children with idiopathic mental retardation in South IndiaUnraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders.Copy Number Variation detection from 1000 Genomes Project exon capture sequencing data.Robust regression analysis of copy number variation data based on a univariate score.Neurogenetic analysis of childhood disintegrative disorder.Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics.De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia.A genome wide association study of mathematical ability reveals an association at chromosome 3q29, a locus associated with autism and learning difficulties: a preliminary study.DNA methylation as a putative mechanism for reduced dendritic spine density in the superior temporal gyrus of subjects with schizophrenia.Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia.Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice.Potential Value of Genomic Copy Number Variations in Schizophrenia.Two non-synonymous markers in PTPN21, identified by genome-wide association study data-mining and replication, are associated with schizophrenia.The genetic variability and commonality of neurodevelopmental disease.Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes.High frequency of known copy number abnormalities and maternal duplication 15q11-q13 in patients with combined schizophrenia and epilepsy.Does epilepsy in multiplex autism pedigrees define a different subgroup in terms of clinical characteristics and genetic risk?Neurogenetics: advancing the "next-generation" of brain research.RNA-Seq analysis implicates dysregulation of the immune system in schizophreniaPAK1 protein expression in the auditory cortex of schizophrenia subjects.Copy number variants in German patients with schizophreniaPopulation-specific haplotype association of the postsynaptic density gene DLG4 with schizophrenia, in family-based association studies.Infection and inflammation in schizophrenia and bipolar disorder: a genome wide study for interactions with genetic variationHomozygous deficiency of ubiquitin-ligase ring-finger protein RNF168 mimics the radiosensitivity syndrome of ataxia-telangiectasia.Contribution of copy-number variation to Down syndrome-associated atrioventricular septal defects.Copy number variants for schizophrenia and related psychotic disorders in Oceanic Palau: risk and transmission in extended pedigrees.Dendritic spine alterations in schizophrenia.Further evidence for a male-selective genetic association of synapse-associated protein 97 (SAP97) gene with schizophreniaRare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autismIndependent estimation of the frequency of rare CNVs in the UK population confirms their role in schizophrenia.
P2860
Q21245451-5802F3D3-03D0-41C3-BA07-98DCA5B7BCB4Q24603800-18914B07-17D8-4B65-98FE-9BD003CB7073Q26752306-F24F8D54-8F3D-4A0B-B83A-81B98D3C879AQ26781213-A648DFCF-4A2B-4CB5-807E-FD249D67FF43Q26824648-7CC5A1CD-1C30-49F8-8E40-483ACB797E8EQ27015135-38A30DE1-A8B9-4324-8CD5-15B807046315Q28081110-ED3C5477-0C0C-4830-A200-16066FBAA808Q28304430-78FE4105-997E-4391-9DFB-F4D237BDC9F2Q28387422-229AD21D-694F-48AA-9FC8-084464BA93CCQ28608266-B6F8B969-3F0D-4D66-96DF-F50273B45A85Q30009572-C9CE6312-F447-4FE8-AB38-4AD140794E65Q30241067-C72DEFB3-D84F-41CC-8D00-A2E08A081B31Q30577661-BCA00C7C-4F66-43ED-945E-E5490F4F4812Q30754963-347B7E49-068A-4AEB-BB93-223C574647F9Q30843918-9CDBD905-70F0-43D8-9E9C-B39C2B4F2F34Q31108616-3317BA9B-8211-48C0-B243-9CCDDB27926CQ33398247-DEC5F778-C3E3-4C89-9C2D-2CC34738A5AFQ33573331-2BD25EFB-2777-420F-9B03-0109D976ECC5Q33707704-D0182F51-9C6E-43A9-8285-BBC5F03197ECQ33740241-FF35A303-BD8D-497D-ABEB-44941337A213Q33772616-8283A3A2-18E6-46AB-A4DA-4970FD658EDEQ33819207-40F03FB1-3C0E-402B-B271-B2750B2E50D9Q33960019-23AA80B5-70C7-4FE6-B22A-57A80ACD88A9Q33965270-10633A9E-6711-4EAA-B49E-8BA9C335CBDDQ33991709-CB701A96-7879-4484-85F6-3D6E11708DD9Q34084054-7D4902C0-7F59-4E28-93FC-AB6EDD5CCD89Q34249436-9E2A106D-6C92-4799-A39E-CB0EE3BE4E86Q34315505-78B8E52B-4ED7-43E2-951E-2A11EE3896A4Q34530641-DD174834-7256-4F61-A934-9EFE7D45AD92Q34683597-97490991-0A45-4D1A-BD00-D4A1887DBCCDQ34811896-4FB634EB-B59B-406A-95DB-DD4E7E47E00EQ34922527-705A5B88-797D-4CF0-9BCB-0EBA3EB2453BQ35187746-3901430F-2025-4DCC-BF3E-097B5FC1E3AAQ35227435-B6B7DF99-A9AA-471B-B271-1A54F634F1FEQ35533264-296FBA51-0A11-46A2-8BEC-B8E657F39107Q35573434-DB807BAF-88A2-4589-98B7-CBACE782E2ADQ35680429-836D70C2-B3F7-4D03-91D4-DE856018C7ADQ35744819-F5C46D10-EA96-425B-A161-35D2B7332DD2Q35764564-0C823AAB-2AF0-4960-BD88-37A3866072A0Q35861470-B36A9CBC-87DE-4330-9C57-3BA8CCED247D
P2860
Microdeletions of 3q29 confer high risk for schizophrenia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Microdeletions of 3q29 confer high risk for schizophrenia.
@ast
Microdeletions of 3q29 confer high risk for schizophrenia.
@en
Microdeletions of 3q29 confer high risk for schizophrenia.
@nl
type
label
Microdeletions of 3q29 confer high risk for schizophrenia.
@ast
Microdeletions of 3q29 confer high risk for schizophrenia.
@en
Microdeletions of 3q29 confer high risk for schizophrenia.
@nl
prefLabel
Microdeletions of 3q29 confer high risk for schizophrenia.
@ast
Microdeletions of 3q29 confer high risk for schizophrenia.
@en
Microdeletions of 3q29 confer high risk for schizophrenia.
@nl
P2093
P2860
P50
P1476
Microdeletions of 3q29 confer high risk for schizophrenia.
@en
P2093
Adele A Mitchell
Ann E Pulver
Anne F Dodd
David J Cutler
David Valle
Jennifer Gladys Mulle
M Katharine Rudd
Nara L Sobreira
Paula S Wolyniec
Stephen T Warren
P2860
P304
P356
10.1016/J.AJHG.2010.07.013
P407
P577
2010-08-01T00:00:00Z